Integral Diagnostics |
Market Cap (23-Oct) $784,763,520 (313th) |
Close (30-Jun) $3.28 |
Volume (30-Jun) 745,243 |
Shortsold (19-Oct) 6,210,334 (1.66%) (185th) |
|
52w High $2.60 |
52w Low $1.86 |
P/E 17.24 |
EPS 0.06 |
[ARTICLE] What we learnt: Appen, NextDC, Helloworld, Integral Diagnostics
A news article has been posted about Integral Diagnostics on the AFR. The article was published around , on 28 August 2023 at 4:30pm.
What’s particularly interesting, though, is that there is no let-up in travel demand, despite sky-high prices and broader cost of living pressures. Helloworld delivered its first guidance for 2024 and is expecting EBITDA of between $64 million and $72 million, which at the midpoint points to growth of 52 per cent.
Read ArticleIDX was $3.28 at the close of trade on 30 June 2023
| Recent Articles about ASX:IDX | |
|---|---|
| 23-Oct | Artrya Limited annual general meeting – notice and proxy form
company-announcements.afr.com |
| 17-Oct | 2026 Notice of Annual General Meeting (AGM) - AFR
company-announcements.afr.com |
| 16-Oct | Release of Ordinary Shares from Escrow - AFR
company-announcements.afr.com |
| 16-Oct | ASX / MEDIA RELEASE - AFR
company-announcements.afr.com |
| 16-Oct | Clover Corporation Limited - AFR
company-announcements.afr.com |
| 13-Oct | WiseTech Global 2026 Annual General Meeting - AFR
company-announcements.afr.com |
| 13-Oct | Change of Director's Interest Notice - AFR
company-announcements.afr.com |
| 12-Oct | ASX Announcement Australian Clinical Labs Limited - AFR
company-announcements.afr.com |
| 12-Oct | Growthpoint Properties Australia - AFR
company-announcements.afr.com |
| 8-Oct | 8.0c 7.0% 8.8% 7.75c 5.7c 478.0c $1.4bn 14.3% $1.135 - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about Integral Diagnostics, including others on the AFR, on the media page.
You must be logged in to post a reply.